Physiological concentrations of estradiol attenuate endothelin 1- induced coronary vasoconstriction in vivo

Circulation

Volumn 96, Issue 10, 1997, Pages 3626-3632

  Sudhir, Krishnankutty ^a   Ko, Eitetsu ^a   Zellner, Christian ^a   Wong, Hubert E ^a   Hutchison, Stuart J ^a   Chou, Tony M ^a   Chatterjee, Kanu ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angina; Blood flow; Endothelin; Hormones

Indexed keywords

ENDOTHELIN 1; ESTRADIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DISEASE; DRUG EFFECT; HEART PROTECTION; IN VIVO STUDY; NONHUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; SWINE;

EID: 0030732109     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.10.3626     Document Type: Article

References (38)

1. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA. 1991;265:1861-1867.
2. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987;75:1102-1109.
3. Ingegno MD, Money SR, Thelmo W, Greene GL, Davidian M, Jaffe BM, Pertschuk LP. Progesterone receptors in the human heart and great vessels. Lab Invest. 1988;59:353-356.
4. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation. 1994;89:1943-1950.
5. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation. 1994;89:1501-1510.
6. Farhat MY, Abi YS, Ramwell PW. Non-genomic effects of estrogen and the vessel wall. Biochem Pharmacol. 1996;51:571-576.
7. Sudhir K, Chou TM, Mullen WL, Hausmann D, Collins P, Yock PG, Chatterjee K. Mechanisms of estrogen-induced vasodilation: in vivo studies in canine coronary conductance and resistance arteries. J Am Coll Cardiol. 1995;26:807-814.
8. Volterrani M, Rosano G, Coats A, Beale C, Collins P. Estrogen acutely increases peripheral blood flow in postmenopausal women. Am J Med. 1995;99:119-122.
9. Sarrel PM, Lindsay D, Rosano GM, Poole WP. Angina and normal coronary arteries in women: gynecologic findings. Am J Obstet Gynecol. 1992;167:467-471.
10. Rosano GM, Sarrel PM, Poole WP, Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet. 1993;342:133-136.
11. Salomone OA, Elliott PM, Calvino R, Holt D, Kaski JC. Plasma immunoreactive endothelin concentration correlates with severity of coronary artery disease in patients with stable angina pectoris and normal ventricular function. J Am Coll Cardiol. 1996;28:14-19.
12. Kaski JC, Elliott PM, Salomone O, Dickinson K, Gordon D, Hann C, Holt DW. Concentration of circulating plasma endothelin in patients with angina and normal coronary angiograms. Br Heart J. 1995;74:620-624.
13. Zeiher AM, Goebel H, Schachinger V, Ihling C. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque: a clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation. 1995;91:941-947.
14. Zeiher AM, Ihling C, Pistorius K, Schachinger V, Schaefer HE. Increased tissue endothelin immunoreactivity in atherosclerotic lesions associated with acute coronary syndromes. Lancet. 1994;344:1405-1406.
15. Wieczorek I, Haynes WG, Webb DJ, Ludlam CA, Fox KA. Raised plasma endothelin in unstable angina and non-Q wave myocardial infarction: relation to cardiovascular outcome. Br Heart J. 1994;72:436-441.
16. Artigou JY, Salloum J, Carayon A, Lechat P, Maistre G, Isnard R, Komajda M, Legrand JC, Grosgogeat Y. Variations in plasma endothelin concentrations during coronary spasm. Eur Heart J. 1993;14:780-784.
17. Chou TM, Sudhir K, Iwanaga S, Chatterjee K, Yock PG. Measurement of volumetric coronary blood flow by simultaneous intravascular two-dimensional and Doppler ultrasound: validation in an animal model. Am Heart J. 1994;128:237-243.
18. Sudhir K, MacGregor JS, Barbant SD, Foster E, Fitzgerald PJ, Chatterjee K, Yock PG. Assessment of coronary conductance and resistance vessel reactivity in response to nitroglycerin, ergonovine and adenosine: in vivo studies with simultaneous intravascular two-dimensional and Doppler ultrasound. J Am Coll Cardiol. 1993;21:1261-1268.
19. Sudhir K, MacGregor JS, Gupta M, Barbant SD, Redberg R, Yock PG, Chatterjee K. Effect of selective angiotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo: intravascular two-dimensional and Doppler ultrasound studies. Circulation. 1993;87:931-938.
20. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JJ. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med. 1991;325:997-1001.
21. Hale SL, Birnbaum Y, Kloner RA. Beta-estradiol, but not alpha-estradiol, reduced myocardial necrosis in rabbits after ischemia and reperfusion. Am Heart J. 1996;258-262.
22. Polderman KH, Stehouwer CD, van Kamp G, Dekker GA, Verheugt FW, Gooren LJ. Influence of sex hormones on plasma endothelin levels. Ann Intern Med. 1993;118:429-432.
23. Ylikorkala O, Orpana A, Puolakka J, Pyorala T, Viinikka L. Post-menopausal hormonal replacement decreases plasma levels of endothelin-1. J Clin Endocrinol Metab. 1995;80:3384-3387.
24. Jiang C, Sarrel PM, Poole WP, Collins P. Acute effect of 17 beta-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am J Physiol. 1992;263:H271-H275.
25. 2+ sensitivity in alpha-toxin-permeabilized rabbit mesenteric artery. Circ Res. 1992;71:951-959.
26. 2+ in guinea-pig isolated cardiac myocytes. Br J Pharmacol. 1992;106:739-745.
27. Barber DA, Sieck GC, Fitzpatrick LA, Miller VM. Endothelin receptors are modulated in association with endogenous fluctuations in estrogen. Am J Physiol. 1996;H1999-H2006.
28. Sudhir K, Chou TM, Messina LM, Hutchison SJ, Korach KS, Chatterjee K, Rubanyi GM. Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene. Lancet. 1997;349:1146-1147.
29. Flynn DA, Sargent CA, Brazdil R, Brown TJ, Roach AG. Sarafotoxin S6c elicits a non-ETA or non-ETB-mediated pressor response in the pithed rat. J Cardiovasc Pharmacol 1995;S219-S221.
30. Warner TD, Allcock GH, Corder R, Vane JR. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF. Br J Pharmacol. 1993;110:777-782.
31. Hayashi T, Yamada K, Esaki T, Kuzuya M, Satake S, Ishikawa T, Hidaka H, Iguchi A. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun. 1995;214:847-855.
32. Sudhir K, Jennings G, Funder J, Komesaroff P. Estrogen enhances basal nitric oxide release in the forearm vasculature in perimenopausal women. Hypertension. 1996;28:330-334.
33. Cannan CR, Burnett JJ, Brandt RR, Lerman A. Endothelin at pathophysiological concentrations mediates coronary vasoconstriction via the endothelin-A receptor. Circulation. 1995;92: 3312-3317.
34. Cox DA, Cohen ML. Selective enhancement of 5-hydroxytryptamine-induced contraction of porcine coronary artery by oxidized low-density lipoprotein. J Pharmacol Exp Ther. 1996;276:1095-1103.
35. Van Nueten JM, Leysen JE, de CF, Vanhoutte PM. Serotonergic receptor subtypes and vascular reactivity. J Cardiovasc Pharmacol. 1984;S564-S574.
36. Cocks TM, Angus JA. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature. 1983;305:627-630.
37. Richard V, Tanner FC, Tschudi M, Luscher TF. Different activation of L-arginine pathway by bradykinin, serotonin, and clonidine in coronary arteries. Am J Physiol. 1990;H1433-H1439.
38. Futo J, Shay J, Block S, Holt J, Beach M, Moss J. Estrogen and progesterone withdrawal increases cerebral vasoreactivity to serotonin in rabbit basilar artery. Life Sci. 1992;50:1165-1172.